Global Webinar Series
Clinical Use of CEM:
Guidelines to Clinical Practice

Join us for a webinar series on the Clinical Use of Contrast Enhanced Mammography: From Guidelines to Clinical Practice. Participants will learn from expert faculty as they provide their clinical experience regarding relevant aspects of CEM. Each case-based webinar is designed to meet the learning needs of Breast Radiologists, Breast Surgeons and Technologists.

Each 30-45 minute presentation will be followed by live interactive Q&A.

Register

Thursday, March 11, 2021
12:00 p.m. EST | 6:00 p.m. CET Timezone Converter
Practical Solutions for Implementation of Contrast Enhanced Mammography

Ryan Gabriel, MD
Virginia, United States

More Information

This webinar will discuss the basics of Contrast Enhanced Mammography (CEM) and provide practical solutions for introducing CEM into your practice. It includes the following objectives:

  • Identifying key equipment and staffing components for the implementation of CEDM
  • Workflow solutions for implementing CEDM in your practice
  • Considerations for utilizing CEDM as a new tool for diagnostic imaging

Biography

Dr. Ryan Gabriel, MD is a board certified Diagnostic Radiologist specializing in Breast Imaging. He is employed by Radiology Associates of Richmond and currently serves as the Director of Breast Imaging at Henrico Doctors' Hospital in Richmond, VA.

Dr. Gabriel obtained his medical degree and completed his residency in Diagnostic Radiology at Virginia Commonwealth University / Medical College of Virginia. He completed a Fellowship in Breast Imaging and Intervention at University of Virginia, Charlottesville, VA.

Thursday, March 25, 2021
12:00 p.m. EDT | 6:00 p.m. CET Timezone Converter
Contrast Enhanced Mammography for Pre-surgical Planning

Linda Han, MD
Indiana, United States

More Information

A key component to successful implementation of Contrast Enhanced Mammography is the pre-surgical planning. In this Webinar an experienced surgeon will provide her clinical expertise on this important aspect. It includes the following objectives:

  • Review current best practice for screening women at high risk for breast cancer
  • Understand role of contrast enhanced mammography in a comprehensive breast program
  • Discuss practical tips for successful implementation and integration of CEM in a breast program

Biography

Following undergraduate and medical school training at Indiana University, Dr. Linda Han completed her surgical residency at The Ohio State University. She was the Director of Breast Surgical Oncology at Indiana University Simon Cancer Center, professor of clinical surgery and section chief of breast surgical oncology in the department of surgery at IU School of Medicine. While there, she established a breast cancer survivorship protocol, recognized nationally as best practice by National Accreditation Program for Breast Centers.

Dr. Han has held numerous positions of leadership focusing on surgical education, quality improvement and care delivery. She joined Parkview Health in January 2017 but remains committed to medical education as adjunct clinical professor of surgery in the School of Medicine at Indiana University.

She currently serves as the Director of Breast Oncology at Parkview Cancer Institute and is the Chief Surgery Quality and Optimization Officer for Parkview Health.

Thursday, April 8, 2021
12:00 p.m. EDT | 6:00 p.m. CET Timezone Converter
Monitoring of Neoadjuvant Chemotherapy (NAC) with Contrast Enhanced Mammography

Nila Alsheik, MD
Illinois, United States

More Information

During this webinar an experienced breast radiologist will discuss important aspects of Monitoring of Neoadjuvant Chemotherapy (NAC) with Contrast Enhanced Mammography. It includes the following objectives:

  • Differentiate between normal enhancing fibroglandular tissue and pathologic enhancement on Contrast Enhanced Mammography (CEM)
  • Discern the degree of radiographic post-Neoadjuvant treatment response on Contrast Enhanced Mammography (CEM)
  • Understand indications for Neoadjuvant Chemotherapy for treatment of Breast Cancer and Utility of CEM in the Pre-Neoadjuvant and Post-Neoadjuvant setting

Biography

Dr. Nila H. Alsheik obtained her medical degree from the Warren Alpert Medical School of Brown University. She completed her Diagnostic Radiology Residency, Neuroradiology and Breast Imaging Fellowships from the University of Wisconsin School of Medicine and Public Health in 2011.

Dr. Alsheik is currently the Chief of Breast Imaging at Advocate Lutheran General Hospital and the Chair of the Breast Imaging Medical Directors Committee for Advocate Health Care, the largest nonprofit health system in Illinois. Clinical interests focus on value-based breast imaging in the era of dense breast inform legislation and radiology resource utilization.

Thursday, April 22, 2021
12:00 p.m. EDT | 6:00 p.m. CET Timezone Converter
Follow-up of B3 Breast Lesions with CEM: Clinical Experience and Emerging Evidence

Jacopo Nori, MD
Florence, Italy

More Information

Update on clinical evidence and use is essential for improving evidence-based health care. CEM is gaining recognition and was recently recommended in the EU guidelines as the preferred solution for pre-surgical planning. During this webinar a skilled radiologist will give an update on clinical use of CEM. It includes the following objectives:

  • Consolidate knowledge of the clinical use of CEM and the potential impact on clinical routine
  • Learn about the current published evidence for clinical use of CEM
  • Understand the potential value and impact on patient pathway implementing CEM

Biography

Dr. Jacopo Nori from the university hospital AOUC (Azienda Ospedaliero-Universitaria Careggi) in Florence where he is leading the breast radiology department. He published the first book on Contrast Enhanced Dual-energy Mammography by Springer in collaboration with other opinion leaders in 2019 and his group have published multiple articles based on their important experience with CEM. Dr Nori is an organizer of congresses and educations events around new technologies and a leader encouraging the development of new talents. His center have done over 2.500 CEM cases and have been using this technology in clinical routine since 2018. A second book "Atlas of Contrast-Enhanced Mammography" was published in January 2021.

Thursday, May 6, 2021
12:00 p.m. EDT | 6:00 p.m. CET Timezone Converter
CEM for Screening in Cases of Intermediate Risk or Very Dense Breasts

Eva Pallwein-Prettner, MD
Steyr, Austria

More Information

How to deal with the limitations of mammography for very dense breasts? To answer this and other related questions, this webinar will cover the clinical experience using CEM in a single institution setting. First a short introduction of the clinical considerations leading to the use of CEM will be presented together with the resulting experience. Then a detailed case review will highlight examples from the clinical routine use. The objectives for this session include:

  • Consolidate knowledge of the clinical use of CEM and the use in a screening setting
  • Learn from a single center experience about the clinical use of using CEM for intermediate risk or very dense breast in screening
  • Understand the impact on patient pathway implementing CEM in screening of women with intermediate risk or very dense breast

Biography

Dr. Eva Pallwein is a consulting radiologist from Gesundheitszentrum in Steyr (Austria) where she is responsible for the breast imaging. She has been focusing on breast cancer detection and diagnosis for over 10 year and she is certified by the EBBI, European Board of Breast Imaging. She is a member of the German-Austrian radiology society where she recently presented her work to the breast focus group through a webinar series. As co-organizer of educational events she has a particular interest in clinical routine use of CEM and in particular the use for managing intermediate risk or very dense breasts.

For additional resources and educational opportunities please visit: www.HologicEd.com

Questions?